---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-077777"
form_type: "8-K"
ticker: "CTXR"
cik: "0001506251"
company_name: "Citius Pharmaceuticals, Inc."
filed_at: "2024-09-11T23:59:59+00:00"
generated_at: "2026-05-31T05:25:53.238379+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Citius Pharma receives Nasdaq delisting determination for bid price non-compliance; plans hearing

## Summary
- Received delisting determination on Sept 10, 2024 after failing to regain $1.00 bid price compliance by extended deadline of Sept 9, 2024.
- Company will request hearing before Nasdaq Hearing Panel, which automatically stays suspension/delisting pending outcome.
- Panel may grant additional extension of up to 180 days from delisting letter date to regain compliance.
- No assurance that relief or continued listing will be granted. Stock trades on Nasdaq Capital Market under CTXR.

## SEC filing metadata
- accession: 0001213900-24-077777
- form_type: 8-K
- ticker: CTXR
- cik: 0001506251
- company_name: Citius Pharmaceuticals, Inc.
- filed_at: 2024-09-11T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1506251/000121390024077777/0001213900-24-077777-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1506251/000121390024077777/ea0214282-8k_citius.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-077777
- JSON: https://secwatch.observer/filing/0001213900-24-077777.json
- Plain text: https://secwatch.observer/filing/0001213900-24-077777.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.